- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04122183
Internet Auditory Rehabilitation: Follow-up to Adult Hearing Screening
July 26, 2024 updated by: Laura N. Galloway, University of Louisville
Internet Auditory Rehabilitation: Innovative Follow-up to Adult Hearing Screening.
The purpose of this study is to see if a newly developed program called "I Manage my hearing loss" (iManage) will increase the number of individuals who visit an audiologist after failing a hearing screening.
The iManage program will educate individuals about hearing loss, demonstrate that hearing problems are important, demonstrate that support from family and friends is important and help participants identify the benefits and concerns related to seeking help for hearing loss.
Study Overview
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- University of Louisville, Program in Audiology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
41 years to 81 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Subject must fail a hearing screening (any threshold >34 decibels hearing level at 2000 or 3000 Hertz in either ear) or show equivalent or greater degree of hearing loss on most recent audiogram.
- Free of obvious outer or middle ear disease (as measured by otoscopy)
- Between the ages of 45 and 85
- Pass a health literacy screening
- Pass a thinking skills screening
Exclusion Criteria:
- Experience seeing an audiologist for a hearing evaluation or management
- Experience using a hearing aid
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Program Group
Following a failed hearing screening, participants will be offered the standard of care (information sheet recommending a comprehensive hearing evaluation) and asked to complete the iManage Program.
Six months after the screening participants will be asked if they visited an audiologist.
|
An internet-based decision coaching guide to help an individual decide if they wish to visit an audiologist.
|
|
No Intervention: Delayed Program Group
Following a failed hearing screening, participants will be offered the standard of care (information sheet recommending a comprehensive hearing evaluation).
Six months after the screening participants will be asked if they visited an audiologist and they will be given the opportunity to complete the iManage Program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Audiologist visit
Time Frame: 6 months following the failed hearing screening
|
The percentage of individuals who visit an audiologist for a comprehensive hearing evaluation.
|
6 months following the failed hearing screening
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change on the Health Belief Questionnaire, a survey that measures attitudes about the 6 constructs of the Health Belief Model as related to seeking hearing healthcare
Time Frame: Baseline (within one week of screening) and 6 months post baseline
|
Mean score (which can range between 1 and 11) on each of 6 scales: perceived susceptibility, perceived severity, perceived benefits, perceived barriers, perceived self-efficacy, and cues to action.
A higher score indicates greater agreement with the construct.
|
Baseline (within one week of screening) and 6 months post baseline
|
|
Change on the Readiness for Change Questionnaire, a single-item questionnaire that attempts to place the participant on a continuum regarding readiness for hearing healthcare as outline by the Transtheoretical Model.
Time Frame: Baseline, 4 weeks post baseline, and 6 months post baseline
|
Participants will select the statement that best describes their view of their hearing status, 1 indicates "precontemplation", 2 indicates "contemplation", 3 indicates, "preparation", 4 indicates "action" on the Transtheoretical Model Continuum.
|
Baseline, 4 weeks post baseline, and 6 months post baseline
|
|
Total score on the Hearing Loss Support Scale, a questionnaire that measures self-perceived informational and emotional support from family, peers, and healthcare providers about managing hearing loss.
Time Frame: Baseline, and 6 months post baseline
|
Total score can range between 7 and 49, with a higher score indicating greater support from others.
|
Baseline, and 6 months post baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Program uptake
Time Frame: 3 months following the failed hearing screening
|
Percentage of experimental participants who begin the iManage program
|
3 months following the failed hearing screening
|
|
Program completion
Time Frame: 3 months following the failed hearing screening
|
Percentage of experimental participants who complete the iManage program
|
3 months following the failed hearing screening
|
|
Mean scores on the Audiology Decision Making Scale, a scale designed to measure preparedness for decision making for 13 specific decision processes
Time Frame: 4 weeks after completion of iManage Program
|
Mean score can range between 1 and 5 with higher scores indicating greater self-perceived usefulness of the iManage Program in making a decision about hearing healthcare.
|
4 weeks after completion of iManage Program
|
|
A focus group of individuals who completed the iManage program to learn participants perceptions about the content, benefits and drawbacks of the iManage program
Time Frame: 6 to 8 weeks after completion of iManage Program
|
Qualitative thematic analysis will indicate common attitudes (themes) about the iManage program
|
6 to 8 weeks after completion of iManage Program
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Laura Galloway, AuD, Professor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 17, 2021
Primary Completion (Actual)
December 30, 2023
Study Completion (Actual)
December 30, 2023
Study Registration Dates
First Submitted
October 8, 2019
First Submitted That Met QC Criteria
October 8, 2019
First Posted (Actual)
October 10, 2019
Study Record Updates
Last Update Posted (Actual)
July 29, 2024
Last Update Submitted That Met QC Criteria
July 26, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15.0663
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
There is no individual participant data (IPD) sharing plan at this time as this is a feasibility study.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss
-
MED-EL Elektromedizinische Geräte GesmbHCompletedHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedAustria, Germany, United Kingdom
-
Oticon MedicalCompletedEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteRecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Noise-Induced | Hearing Loss, Unilateral | Hearing Loss, Mixed | Hearing Disorders in ChildrenUnited States
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Truway Health, Inc.Enrolling by invitationSensorineural Hearing Loss | Tinnitus | Sudden Hearing Loss | Acoustic Trauma | Inner Ear Injury | Noise-Induced Hearing Loss | Vestibular DysfunctionUnited States
-
Wonju Severance Christian HospitalRecruitingHearing Loss, Sudden | Sudden Hearing Loss | Hearing Loss, Idiopathic Sudden Sensorineural | SSNHL(Sudden Sensory Neural Hearing Loss)Korea, Republic of
-
Envoy Medical CorporationActive, not recruitingSensorineural Hearing Loss | Sensorineural Hearing Loss (Disorder) | Sensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound | Sensori-Neural DeafnessUnited States
-
Oticon MedicalCompletedConductive Hearing Loss | Conductive and Sensori-neural Hearing Loss in the Same Ear | Unilateral, Profound Sensori-neural Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
Clinical Trials on iManage (my hearing loss)
-
US Department of Veterans AffairsCompleted
-
Virginia Polytechnic Institute and State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...Completed
-
BioSpeechOregon Health and Science UniversityCompletedHearing Loss | Hearing Impairment | Hearing Impaired ChildrenUnited States
-
US Department of Veterans AffairsCompleted
-
University of MichiganCompleted
-
University of ManchesterSonova AGCompletedCognitive Performance | Fatigue, Mental | Communication Barriers | Quality of Life (QOL)United Kingdom
-
University of South FloridaNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingHearing LossUnited States
-
Seoul National University HospitalAmgenRecruitingMinimal Residual Disease | Pediatric ALL, B CellKorea, Republic of
-
Amgen Research (Munich) GmbHCompletedAcute Lymphoblastic LeukemiaUnited States, United Kingdom, Germany, Spain, France, Italy
-
Royal Cornwall Hospitals TrustUniversity of Birmingham; University of ExeterNot yet recruitingTinnitus | Hearing Loss, Adult-OnsetUnited Kingdom